Mediator MED18 subunit plays a negative role in transcription via the CDK/cyclin module

Masayuki Kumafuji1, Hiroyasu Umemura, Tadashi Furumoto

  • 1Laboratory of Gene Regulation, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.

Insights

The human Mediator complex subunit hMED18 represses transcription, independent of HDAC activity. Its depletion releases repression, revealing a novel mechanism involving hCDK8 and a positive role for the CDK/cyclin module in activation.

Area of Science:

  • Molecular Biology
  • Gene Regulation
  • Eukaryotic Transcription

Background:

  • The Mediator complex is a conserved eukaryotic transcriptional co-activator.
  • The head module, including hMED18, interacts with RNA polymerase II and general transcription factors.
  • Understanding hMED18's role is crucial for elucidating Mediator's dual function in transcription.

Purpose of the Study:

  • To investigate the function of the human Mediator complex head module subunit, hMED18.
  • To determine hMED18's role in transcriptional activation and repression.
  • To elucidate the mechanism underlying hMED18-mediated transcriptional regulation.

Main Methods:

  • siRNA-mediated depletion of hMED18.
  • Treatment with histone deacetylase (HDAC) inhibitors (trichostatin A and nicotinamide).
  • Chromatin immunoprecipitation (ChIP) to assess protein binding at target gene promoters (RAM/FAM103A1 and DMT1/SLC11A2).

Main Results:

  • hMED18 depletion led to increased transcription, indicating a repressive role for hMED18.
  • hMED18-mediated repression was not dependent on HDAC activity.
  • hMED18 depletion caused the loss of hMED18 and hMED1 from target gene promoters, while hCDK8 remained bound, suggesting a novel repression mechanism.
  • This mechanism involves hMED18, hCDK8, and the middle module subunit hMED1.

Conclusions:

  • hMED18 functions as a transcriptional repressor.
  • A novel mechanism of transcriptional repression mediated by hMED18 and hCDK8 was identified.
  • The study suggests a novel positive role for the free CDK/cyclin module in transcriptional activation.

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.3K
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
100.8K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.1K
Master Transcription Regulators02:23

Master Transcription Regulators

1.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K